Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

12345678910

IN BRIEF: GSK non-executive director buys nearly GBP75,000 in shares

20th Feb 2026 15:50

GSK PLC - London-based pharmaceuticals company - Independent Non-Executive Director Wendy Becker buys 3,334 shares, at GBP22.19, worth GBP73,990, on Friday in London. Read More

LONDON BROKER RATINGS: Shore raises Sage, UBS raises St James's Place

20th Feb 2026 09:29

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

GSK starts GBP450 million buyback tranche as EU approves Exdensur drug

17th Feb 2026 12:54

(Alliance News) - GSK PLC on Tuesday announced the beginning of the fourth tranche of a GBP2 billion buyback programme, worth GBP450 million. Read More

LONDON BROKER RATINGS: Peel Hunt cuts InterContinental Hotels - 'hold'

17th Feb 2026 09:50

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

LONDON BROKER RATINGS: Bernstein, Barclays and Deutsche lower Relx

13th Feb 2026 09:51

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON BRIEFING: NatWest results ahead of forecasts, ups dividend 51%

13th Feb 2026 07:58

(Alliance News) - NatWest beats annual earnings expectations and boosts shareholder returns, while AstraZeneca reports positive late-stage trial data for Breztri in asthma, as UK retail footfall improves from a weak Christmas period but remains below last year's levels. Read More

UK dividends calendar - next 7 days

12th Feb 2026 17:26

Read More

GSK RSV vaccine Arexvy accepted for review in China for adults over 60

10th Feb 2026 10:17

(Alliance News) - GSK PLC on Tuesday said its respiratory syncytial virus vaccine Arexvy has been accepted for review by China's Center for Drug Evaluation for adults aged 60 and over. Read More

LONDON BROKER RATINGS: Deutsche cuts Unilever; Jefferies cuts Greggs

9th Feb 2026 09:28

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

IN BRIEF: GSK Chair Jonathan Symonds buys GBP53,000 in shares

6th Feb 2026 16:18

GSK PLC - London-based pharmaceuticals company - GSK Non-Executive Chair Jonathan Symonds buys 2,500 shares, at a price of GBP21.14, worth GBP52,850, on Thursday in London. Read More

LONDON BROKER RATINGS: Oddo BHF cuts Wizz Air and Ryanair

6th Feb 2026 09:37

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday: Read More

LONDON MARKET OPEN: FTSE 100 falls as AI fears pressure data stocks

6th Feb 2026 09:15

(Alliance News) - Stock prices in London opened lower on Friday, as renewed fears around artifical intelligence investment spread from the US while software and data stocks came under pressure. Read More

EU regulator greenlights GSK lung disease therapy Nucala

6th Feb 2026 08:37

(Alliance News) - GSK PLC on Friday said the European Commission has approved Nucala, or mepolizumab, as add-on therapy for adults with chronic obstructive pulmonary disease. Read More

LONDON BRIEFING: UK house prices rise more than expected in January

6th Feb 2026 07:55

(Alliance News) - UK house prices rise more sharply than expected, GSK wins approval for Nucala to treat chronic obstructive pulmonary disease in the EU, while Victrex backs its annual guidance. Read More

LONDON MARKET CLOSE: US tech malaise, mining deal flop weigh on FTSE

5th Feb 2026 16:58

(Alliance News) - Stocks in London slumped on Thursday, tracking US and European counterparts, as investors weighed rate calls in Europe and the UK and as merger talks between Glencore and Rio Tinto collapsed once more. Read More

LONDON BROKER RATINGS: Berenberg cuts Fresnillo; Citi cuts Babcock

5th Feb 2026 09:48

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Friday: Read More

LONDON MARKET CLOSE: FTSE 100 tops 10,400 as Beazley and Entain soar

4th Feb 2026 17:01

(Alliance News) - The FTSE 100 surged to a fresh high on Wednesday, spurred by strong trading updates and as insurer Beazley said it has accepted a possible GBP8.0 billion bid. Read More

LONDON MARKET MIDDAY: FTSE 100 strengthens as Beazley and GSK rise

4th Feb 2026 12:06

(Alliance News) - Stock prices in London were higher at midday on Wednesday, despite ongoing jitters over the impact of the latest artificial intelligence developments, as Beazley, DCC and GSK helped the FTSE 100 reach a fresh record. Read More

GSK optimistic for 2026 after fourth-quarter results beat forecast

4th Feb 2026 08:54

(Alliance News) - GSK PLC on Wednesday backed guidance after fourth-quarter results beat expectations, driven by growth in its Specialty Medicines and Vaccines divisions and lower-than-expected expenses. Read More

LONDON BRIEFING: Zurich agrees terms for GBP8.0 billion Beazley offer

4th Feb 2026 07:58

(Alliance News) - Beazley agrees to takeover terms for a GBP8.0 billion takeover by Zurich Insurance, while GSK reports "another strong performance" helped by its Specialty Medicines arms. Read More

12345678910
FTSE 100 Latest
Value10,709.44
Change-33.91